共 3 条
[1]
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
[J].
ARTHRITIS AND RHEUMATISM,
2005, 52 (10)
:3279-3289
[2]
Schentag CT, 2002, ARTHRITIS RHEUM-US, V46, pS424
[3]
Schentag CT, 1999, J RHEUMATOL, V26, P1627